KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to $9.0 million.

  • Nektar Therapeutics' Net Cash Flow fell 189.08% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 131.29%. This contributed to the annual value of $9.0 million for FY2024, which is 116.94% up from last year.
  • Nektar Therapeutics' Net Cash Flow amounted to $9.0 million in FY2024, which was up 116.94% from -$53.0 million recorded in FY2023.
  • Nektar Therapeutics' 5-year Net Cash Flow high stood at $102.6 million for FY2020, and its period low was -$173.6 million during FY2021.
  • In the last 3 years, Nektar Therapeutics' Net Cash Flow had a median value of $9.0 million in 2024 and averaged $6.4 million.
  • In the last 5 years, Nektar Therapeutics' Net Cash Flow soared by 204.20% in 2020 and then crashed by 269.29% in 2021.
  • Yearly analysis of 5 years shows Nektar Therapeutics' Net Cash Flow stood at $102.6 million in 2020, then plummeted by 269.29% to -$173.6 million in 2021, then skyrocketed by 136.47% to $63.3 million in 2022, then tumbled by 183.70% to -$53.0 million in 2023, then surged by 116.94% to $9.0 million in 2024.